Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
-
Redfin Reports Record-High Monthly Payments Chill Spring Selling Season—But Declining Rates Could Boost Activity
-
Frontier Publishes 2023 Sustainability Report
-
Palmetto Citizens FCU Deepens Partnership with NCR Atleos to Include Allpoint ATM Network
-
Kantata Ignites Revenue Growth for Professional Services Organizations
-
NICE Named the Conversational Intelligence Market Leader in 2024 Opus Research Intelliview Report
-
Edete Expands Precision Pollination Services in California and Arizona, Quadrupling Pistachio Pollination Areas
-
Cerevance Presents at IAPRD XXIX World Congress on Parkinson’s Disease and Related Disorders
-
Quaker Houghton Announces CFO Transition
-
Introducing LRG: Revolutionizing the Classic Land Rover Defender Experience
-
AEON Biopharma Provides Update on Development Pipeline
-
FloodFlash Launches New Dealer Program for Widely Neglected Sector
-
Jeffrey Haller Joins Evercore as Senior Managing Director in the Financial Institutions Group
-
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
-
ON24 to Participate in the Upcoming 19th Annual Needham Technology, Media, & Consumer Conference
-
New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US
-
PulteGroup’s Presentation at the J.P. Morgan 17th Annual Homebuilding & Building Products Conference to be Webcast Live
-
Wells Fargo & Company Announces Full Redemption of its Series S Preferred Stock and Related Depositary Shares
-
IBM Introduces New Microsoft Copilot Capabilities to Fuel AI-Powered Business Transformation
-
Stryker declares a $0.80 per share quarterly dividend
-
JACK HENRY & ASSOCIATES ANNOUNCES REGULAR QUARTERLY DIVIDEND
-
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
-
Meet-up in 798: the Global Art Destination Captivates 300,000 visitors with Cultural Extravaganza During May Day Holiday
-
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
-
Terra CO2 Enters Permitting Stage for High-Performance Cement Extender Plant in Texas, Creating a Near-Term Solution for Increased Production and Carbon Reduction
-
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
-
ACELYRIN, INC. Announces Leadership Transition
-
Energy Vault, ACEN Australia Announce Agreement for 400 MWh of Battery Energy Storage Deployments
-
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
-
Salesloft Welcomes Sara Cohen as Chief People Officer
-
Fulcrum Therapeutics to Participate in Upcoming May Conferences
-
ECI Unveils Dynamic New Identity: A Fresh Vision for Global Leadership
-
Xunlei Limited Schedules 2024 Unaudited First Quarter Earnings Release on May 16, 2024
-
The Attivo Group Successfully Achieves (SOC) 1, Type 2 Compliance
-
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
-
CareCloud Retains Citizens JMP as its Exclusive Capital Structure Advisor
-
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea
-
Annexon Biosciences to Present at the Bank of America Health Care Conference
-
Treasure Global’s ZCITY Secures US$2Million Marketing Contract through its AI Marketing Engine
-
US Squash Announces the Launch of the U.S. Squash Foundation
-
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Stryker declares a $0.80 per share quarterly dividend
-
Direct Travel Continues Growth Momentum with New Additions to Executive Team
-
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
-
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
-
Motiv Completes Delivery of Additional 55 Electric Trucks to Purolator
-
red violet to Present at the B. Riley 24th Annual Institutional Investor Conference
-
Spotless Brands on Expanded Growth Path for a Strong Start to 2024
-
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
-
WisdomTree Announces Launch of India Equity Hedged Fund (INDH)


